China bars Glaxo finance chief from leaving

Published: .
Updated: .

Drug manufacturer GlaxoSmithKline, under investigation in China on suspicion its employees bribed doctors, says its finance director for the country has been barred from leaving.

The British company said Thursday the executive, Steve Nechelput, has not been questioned or arrested and is free to travel within China. It said he continues to work in his role as finance director for the company's China unit.

Chinese police announced this week they believe GSK employees paid bribes to doctors, hospitals and others to encourage them to prescribe the company's medications.

(Copyright 2013 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.)